The implication of mitochondria in chronic fatigue;Implicación de la mitocondria en la fatiga crónica

DOLOR

Volumn 23, Issue 1, 2008, Pages 18-24

  Poca Dias, Violant ^a,d   Ojanguren Saban I ^b   Pereira Dos Santos, C ^c   Sanchez Vizcaino E ^a   Ariza Fernandez A ^b   Garcia Fructuoso F ^a  

^a Centro Internacional de Medicina Avanzada   (Spain)

^b HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^c UNIVERSITY OF THE AZORES   (Portugal)

^d NONE   (Spain)

Author keywords

Chronic fatigue; Exercise intolerance; Mitochondrial myopathy

Indexed keywords

ADULT; ARTICLE; CHRONIC FATIGUE SYNDROME; CLINICAL ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENZYME ACTIVITY; EXERCISE TEST; FEMALE; HUMAN; HUMAN TISSUE; MALE; MEDICAL RECORD REVIEW; MITOCHONDRION; MUSCLE BIOPSY;

EID: 47149086775     PISSN: 02140659     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Assefi NP, Coy TV, Uslan D, Smith WR, Buchwald D. Financial, occupational and personal consequences of disability in patients with chronic fatigue syndrome and fibromyalgia compared to other fatiguing conditions. J Rheumatol. 2003;30:804-8.
2. Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG, Komaroff A. The chronic fatigue syndrome: a comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Study Group. Ann Intern Med. 1994;121:953-9.
3. Arpino C, Carrieri MP, Valesini G, et al. Idiopathic chronic fatigue and chronic fatigue syndrome: a comparison of two case-definitions. Ann 1st Super Sanita. 1999;35:435-41.
4. Pieczenik SR, Neustadt J. Mitochondrial dysfunction and molecular pathways of disease. Exp Mol Pathol. 2007.
5. DiMauro S, Gurgel-Giannetti J. The expanding phenotype of mitochondrial myopathy. Curr Opin Neurol. 2005;18:538-42.
6. DiMauro S. Mitochondrial myopathies. Curr Opin Rheumatol. 2006; 18:636-41.
7. Sarnat HB, Marín-García J. Pathology of mitochondrial encephalomyopathies. Can J Neurol Sci. 2005;32:152-66.
8. Taivassalo T, Jensen TD, Kennaway N, DiMauro S, Vissing J, Haller RG. The spectrum of exercise tolerance in mitochondrial myopathies: a study of 40 patients. Brain 2003;126:413-23.
9. Snell CR, Vanness JM, Strayer DR, Stevens SR. Exercise capacity and immune function in male and female patients with chronic fatigue syndrome (CFS). In Vivo 2005;19:387-90.
10. Behan WM, More IA, Behan PO. Mitochondrial abnormalities in the postviral fatigue syndrome. Acta Neuropathol (Berl). 1991;83:61-5.
11. Preedy VR, Smith DG, Salisbury JR, Peters TJ. Biochemical and muscle studies in patients with acute onset post-viral fatigue syndrome. J Clin Pathol 1993;46:722-6.
12. Vecchiet L, Montanari G, Pizzigallo E, et al. Sensory characterization of somatic parietal tissues in humans with chronic fatigue syndrome. Neurosci Lett. 1996;208:117-20.
13. Chronic fatigue syndrome. Clinical practice guidelines. Med J Aust. 2002;176Suppl:S23-S56.
14. Cohen BH, Gold DR. Mitochondrial cytopathy in adults: what we know so far. Cleve Clin J Med. 2001;68:625-42.
15. Guides to the Evaluation of Permanent Impairement. 5th ed. Chicago, Illinois: American Medical Association, 2002. p. 101.
16. Bourgeois JM, Tarnopolsky MA. Pathology of skeletal muscle in mitochondrial disorders. Mitochondrion. 2004;4:441-52.
17. Wiedemann FR, Vielhaber S, Schroder R, Elger CE, Kunz WS. Evaluation of methods for the determination of mitochondrial respiratory chain enzyme activities in human skeletal muscle samples. Anal Biochem. 2000;279:55-60.
18. Kendall MG, Gobbons JD. Rank correlation methods. 5th ed. 1990.
19. Kalman B, Laitinen K, Komoly S. The involvement of mitochondria in the pathogenesis of multiple sclerosis. J Neuroimmunol. 2007.
20. Weijers RN, Bekedam DJ. Relationship between gestational diabetes mellitus and type 2 diabetes: evidence of mitochondrial dysfunction. Clin Chem. 2007;53:377-83.
21. Blanco FJ, López-Armada MJ, Maneiro E. Mitochondrial dysfunction in osteoarthritis. Mitochondrion. 2004;4:715-28.
22. Beal MF. Mitochondria, oxidative damage, and inflammation in Parkinson's disease. Ann N Y Acad Sci. 2003;991:120-31.
23. Da Silva EM, Soares AM, Moreno AJ. The use of the mitochondrial transmembrane electric potential as an effective biosensor in ecotoxicological research. Chemosphere. 1998;36:2375-90.
24. Darbishire L, Ridsdale L, Seed PT. Distinguishing patients with chronic fatigue from those with chronic fatigue syndrome: a diagnostic study in UK primary care. Br J Gen Pract. 2003;53:441-5.
25. Stouten B. Identification of ambiguities in the 1994 chronic fatigue syndrome research case definition and recommendations for resolution. BMC Health Serv Res. 2005;5:37.
26. Carruthers BM, Jain AK, De Meirleir KL, et al. Myalgic encephalomyelitis/chronic fatigue syndrome: Clinical working case definition, diagnostic and treatment protocols. J Chronic Fatigue Syndr. 2003;11:7-115.
27. Jason LA, Corradi K, Torres-Harding S, Taylor RR, King C. Chronic fatigue syndrome: the need for subtypes. Neuropsychol Rev. 2005;15:29-58.
28. Pall ML. Common etiology of posttraumatic stress disorder, fibromyalgia, chronic fatigue syndrome and multiple chemical sensitivity via elevated nitric oxide/peroxynitrite. Med Hypotheses 2001;57:139-45.
29. Jason LA, Taylor RR, Kennedy CL. Chronic fatigue syndrome, fibromyalgia, and multiple chemical sensitivities in a community-based sample of persons with chronic fatigue syndrome-like symptoms. Psychosom Med. 2000;62:655-63.
30. Fernández-Solá J, Lluís PM, Nogué XS, Munné MP. [Chronic fatigue syndrome and multiple chemical hypersensitivity after insecticide exposure]. Med Clin (Barc). 2005;124:451-3.